| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 503.258 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 371.652 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 354.462 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 563.627 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 408.984 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 381.153 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 339.424 | 88 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 519.936 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 449.575 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 355.426 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 487.522 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 491.365 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 519.646 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 410.659 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 424.06 | 90 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 464.536 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 476.267 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 444.882 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 548.57 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 523.837 | 92 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 535.903 | 92 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 508.058 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 412.044 | 90 |